Skip to main content

Day: June 14, 2022

Balchem Corporation Signs Definitive Agreement to Acquire Kappa Bioscience AS

NEW HAMPTON, N.Y., June 14, 2022 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ:BCPC), a global specialty ingredients company focused on Nutrition and Health, has signed a definitive agreement to acquire Kappa Bioscience AS (“Kappa”), a leading science-based manufacturer of specialty vitamin K2 for the human nutrition industry, headquartered in Oslo, Norway. Vitamin K2 is a fast-growing specialty vitamin that plays a crucial role in the human body for bone health, heart health, immunity, and athletic performance. Primarily, vitamin K2 supports the transport and distribution of calcium in the body. Vitamin K2 is important at all life stages, from pregnancy and early life to healthy aging. Kappa’s K2VITAL® branded vitamin K2 is the leading synthetic vitamin K2 and is backed by strong intellectual property and a deep clinical research...

Continue reading

Trillerverz and SeaChange Agree to Mutually Terminate Proposed Merger

LOS ANGELES, June 14, 2022 (GLOBE NEWSWIRE) — Trillerverz, the AI-powered open garden platform for creators and SeaChange International, Inc. (NASDAQ: SEAC), (“SeaChange” or the “Company”) a leading provider of video delivery, advertising, streaming platforms, and emerging FAST (Free Ad-Supported Streaming TV services) development, have mutually agreed to terminate their proposed merger that was signed on December 22, 2021 (the “Merger Agreement”). The parties have mutually agreed to terminate the Merger Agreement today, as it is no longer possible to complete the merger prior to its termination date of June 30, 2022. The parties have also decided not to seek an extension to the Merger Agreement. The termination is effective immediately. About TrillerverzTrillerverz is the globally popular AI-powered social media and music...

Continue reading

Sio Gene Therapies Announces Fiscal Year 2021 Year-End Financial Results

NEW YORK and DURHAM, N.C., June 14, 2022 (GLOBE NEWSWIRE) — Sio Gene Therapies Inc. (NASDAQ: SIOX) today provided financial results for its fiscal year ended March 31, 2022. Fiscal Fourth Quarter Financial Summary For the fourth fiscal quarter ended March 31, 2022, research and development expenses were $12.6 million, an increase of $4.4 million compared to the prior year quarter. The current period increase was primarily related to increased AXO-AAV-GM1 clinical trial material manufacturing expenses. General and administrative expenses for the fourth fiscal quarter ended March 31, 2022 were $0.5 million, a decrease of $3.5 million compared to the prior year quarter. $3.4 million of the decrease was stock-based compensation expense primarily associated with a reversal of expense related to certain equity instruments of our affiliate,...

Continue reading

GURU Organic Energy Announces Second Quarter 2022 Financial Results

Record Q2 2022 net revenue of $7.6 million, up from $7.1 million in Q2 2021 GURU continues to be the fastest-growing energy drink in Canada in the last 52 weeks1 and the #1 energy drink brand among adults under 25 in Quebec, the next generation of energy drink consumers2 Volume growth of 26% as a result of higher velocities, new product launches and increased points of sale in Canada, and entry in the U.S. club channel Sustained, strong gross margin of 54% compared to 55% in Q1 2022, reflecting careful supply chain management and prudent pricing practices Launch of the “Made in Plants” marketing campaign and introduction of GURU Guayusa Tropical Punch across Canada, following the successful launch in Quebec where it is ranked #1 ‘Innovation SKU’3 Strong financial position with over $62 million in cash and cash equivalents, short-term...

Continue reading

Locafy ramps up acquisition and partnership strategy

HighlightsLocafy continues to grow through partnership and acquisition strategy. Nasdaq invites the Perth-based tech company to ring the opening bell in recognition of it being the first West Australia company to directly list on the global stock exchange.PERTH, AUSTRALIA, June 14, 2022 (GLOBE NEWSWIRE) — Locafy Limited (NASDAQ: LCFY, LCFYW) (“Locafy” or “the Company”), has acquired the client base of Australian digital agency 180 Degree Marketing (180 Degree) as it ramps up its acquisition and partnership strategy. Based in Canberra, Australia 180 Degree services a number of national brands in the real estate, FMCG and finance sectors. Locafy’s goal is to revolutionize the $700 billion search engine optimization market globally through seamlessly deploying to local businesses its patented search technology. “The strategic...

Continue reading

Contact Center Agents Struggle with Traditional Desktop tools to Handle Customer Queries, Survey Finds

BenchmarkPortal’s one-of-a-kind agent experience survey, sponsored by eGain, reveals that contact center agents continue to get hamstrung in the post-pandemic era by lack of knowledge-based guidance SUNNYVALE, Calif., June 14, 2022 (GLOBE NEWSWIRE) — eGain Corporation (NASDAQ: EGAN), the leading knowledge management platform for customer engagement automation, today announced findings from a groundbreaking agent experience (AX) survey of US contact centers. Conducted by BenchmarkPortal, the leading contact center benchmarking organization, the online survey was fielded in May 2022 and findings compiled from 456 responses. Unlike other surveys, the sample included only contact center agents. Here are key findings:Environment76% of respondents still work from home, a surprisingly high percentage, given the easing of Covid restrictionsKnowledge63%...

Continue reading

XCPCNL Business Services Welcome Leah Daniels-Butler to the Company’s Advisory Board

XCPCNL Business Services Welcome Leah Daniels-Butler to the Company’s Advisory Board Leah Daniels-ButlerCharlotte, North Carolina, June 14, 2022 (GLOBE NEWSWIRE) — XCPCNL Business Services Corporation (OTC Pink: XCPL), a venture development business that leverages knowledge, skill, and experience in the consumer products industry, is honored to welcome Leah Daniels-Butler to the Company’s Advisory Board. Leah Daniels-Butler began making a name for herself in the early ’90s working on TV & film projects such as the Wayans Brothers, For Your Love, CB4 and The Inkwell. With an eye for talent, Leah is credited for launching the careers of talented actors like Gabourey Sidebe, star of the Academy Award-winning film “Precious”. She also assisted in casting actor/recording star Tyrese Gibson in the Coca-Cola ad that launched...

Continue reading

Radisson commences a Field program in the Pontiac Group south of the Larder-Lake-Cadillac Break at the O’Brien gold project

Figure 1 Geological and structural data compilationFigure 2 Geophysical data compilation – Southern portion of the O’Brien projectFigure 3 Prospecting plan and supporting infrastructureROUYN-NORANDA, Quebec, June 14, 2022 (GLOBE NEWSWIRE) — Radisson Mining Resources Inc. (TSX-V: RDS, OTC: RMRDF): (“Radisson” or the “Company”) is pleased to announce that it has commenced a field program focused on the 54 km2 area comprising claims located to the south of the prolific Larder-Lake Cadillac Break. The program was designed following a compilation and interpretation of available historical data, with the objective of evaluating opportunities demonstrating strong discovery potential in the southern sector of the O’Brien Gold Project. “Since acquiring and integrating the New Alger property with the O’Brien project...

Continue reading

Clover Doses First Patient with SCB-219M in Phase 1 Trial for Chemotherapy-Induced Thrombocytopenia

— Phase 1 study to evaluate the safety, tolerability, pharmacokinetics and efficacy of SCB-219M in cancer patients with chemotherapy-induced thrombocytopenia, a serious treatment-associated platelet count disorder — — Interim safety and recommended Phase 2 dose anticipated in first half of 2023 — SHNAGHAI, China, June 14, 2022 (GLOBE NEWSWIRE) — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates today announced that the first patient has been dosed with SCB-219M, an innovative thrombopoietin receptor agonist (TPO-RA) mimetic Fc-fusion protein, in a Phase 1 clinical trial to evaluate the safety, tolerability, immunogenicity, pharmacokinetics, and efficacy of SCB-219M in cancer patients with chemotherapy-induced...

Continue reading

Stantec selected to lead construction management for zero-emission Blue Line Bus Rapid Transit in Indianapolis

The city’s third BRT line will provide critical connections to the airport and other important routes EDMONTON, Alberta and NEW YORK and INDIANAPOLIS, June 14, 2022 (GLOBE NEWSWIRE) — TSX, NYSE: STN  Stantec, a global leader in sustainable design and engineering, has been selected to lead construction management for the US$220 million Blue Line Bus Rapid Transit (BRT) project in the City of Indianapolis. Once completed, it will be the city’s third BRT route, providing critical connections to the airport, the existing Red Line and planned Purple Line, and other frequent and local bus routes in the system. The 24-mile, all battery-electric bus system will follow the path of the existing Route 8, providing safer and more reliable services to communities that rely on transit and have the largest concentration of zero-car households. “We...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.